WEST PHARMACEUTICAL SERVICES, INC. Other Comprehensive Income (Loss), before Reclassifications, Net of Tax
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Other Comprehensive Income (Loss), before Reclassifications, Net of Tax of -$42.20 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-04-24.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax · last filed 2020-04-24
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2020-03-31 was -$42.20M, a 3616.67% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2019-12-31 was $21.90M.
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2019-09-30 was -$16.30M.
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2019-06-30 was $1.60M.
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), before reclassifications, net of tax for fiscal 2019 was $8.40M.
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), before reclassifications, net of tax for fiscal 2018 was -$37.70M, a 156.44% decline from fiscal 2017.
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), before reclassifications, net of tax for fiscal 2017 was $66.80M.
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), before reclassifications, net of tax for fiscal 2016 was -$28.70M.
| Period end | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 3 month | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 6 month | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 9 month | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 12 month |
|---|---|---|---|---|
| 2020-03-31 | -$42.20M 10-Q · filed 2020-04-24 | -$20.30M derived: sum of 2 quarters · filed 2020-04-24 | -$36.60M derived: sum of 3 quarters · filed 2020-04-24 | -$35.00M derived: sum of 4 quarters · filed 2020-04-24 |
| 2019-12-31 | $21.90M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $5.60M derived: sum of 2 quarters · filed 2020-02-24 | $7.20M derived: sum of 3 quarters · filed 2020-02-24 | $8.40M 10-K · filed 2020-02-24 |
| 2019-09-30 | -$16.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-29 | -$14.70M derived: sum of 2 quarters · filed 2019-10-29 | -$13.50M 10-Q · filed 2019-10-29 | -$13.80M derived: sum of 4 quarters · filed 2020-02-24 |
| 2019-06-30 | $1.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-29 | $2.80M 10-Q · filed 2019-07-29 | $2.50M derived: sum of 3 quarters · filed 2020-02-24 | -$7.30M derived: sum of 4 quarters · filed 2020-02-24 |
| 2019-03-31 | $1.20M 10-Q · filed 2019-05-08 | $900.00K derived: sum of 2 quarters · filed 2020-02-24 | -$8.90M derived: sum of 3 quarters · filed 2020-02-24 | -$57.10M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-12-31 | -$300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | -$10.10M derived: sum of 2 quarters · filed 2020-02-24 | -$58.30M derived: sum of 3 quarters · filed 2020-02-24 | -$37.70M 10-K · filed 2020-02-24 |
| 2018-09-30 | -$9.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | -$58.00M derived: sum of 2 quarters · filed 2018-10-30 | -$37.40M 10-Q · filed 2018-10-30 | -$24.80M derived: sum of 4 quarters · filed 2019-02-28 |
| 2018-06-30 | -$48.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-31 | -$27.60M 10-Q · filed 2018-07-31 | -$15.00M derived: sum of 3 quarters · filed 2019-02-28 | $5.20M derived: sum of 4 quarters · filed 2019-02-28 |
| 2018-03-31 | $20.60M 10-Q · filed 2018-05-08 | $33.20M derived: sum of 2 quarters · filed 2019-02-28 | $53.40M derived: sum of 3 quarters · filed 2019-02-28 | $79.90M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-12-31 | $12.60M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $32.80M derived: sum of 2 quarters · filed 2019-02-28 | $59.30M derived: sum of 3 quarters · filed 2019-02-28 | $66.80M 10-K · filed 2019-02-28 |
| 2017-09-30 | $20.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | $46.70M derived: sum of 2 quarters · filed 2017-10-31 | $54.20M 10-Q · filed 2017-10-31 | $8.70M derived: sum of 4 quarters · filed 2018-02-26 |
| 2017-06-30 | $26.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $34.00M 10-Q · filed 2017-08-01 | -$11.50M derived: sum of 3 quarters · filed 2018-02-26 | -$5.80M derived: sum of 4 quarters · filed 2018-02-26 |
| 2017-03-31 | $7.50M 10-Q · filed 2017-05-05 | -$38.00M derived: sum of 2 quarters · filed 2018-02-26 | -$32.30M derived: sum of 3 quarters · filed 2018-02-26 | -$35.20M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-12-31 | -$45.50M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | -$39.80M derived: sum of 2 quarters · filed 2018-02-26 | -$42.70M derived: sum of 3 quarters · filed 2018-02-26 | -$28.70M 10-K · filed 2018-02-26 |
| 2016-09-30 | $5.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-31 | $2.80M derived: sum of 2 quarters · filed 2016-10-31 | $16.80M 10-Q · filed 2016-10-31 | $7.70M derived: sum of 4 quarters · filed 2017-02-28 |
| 2016-06-30 | -$2.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-01 | $11.10M 10-Q · filed 2016-08-01 | $2.00M derived: sum of 3 quarters · filed 2017-02-28 | -$23.70M derived: sum of 4 quarters · filed 2017-02-28 |
| 2016-03-31 | $14.00M 10-Q · filed 2016-05-06 | $4.90M derived: sum of 2 quarters · filed 2017-02-28 | -$20.80M derived: sum of 3 quarters · filed 2017-02-28 | -$11.40M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-12-31 | -$9.10M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | -$34.80M derived: sum of 2 quarters · filed 2017-02-28 | -$25.40M derived: sum of 3 quarters · filed 2017-02-28 | -$77.20M 10-K · filed 2017-02-28 |
| 2015-09-30 | -$25.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | -$16.30M derived: sum of 2 quarters · filed 2015-11-02 | -$68.10M 10-Q · filed 2015-11-02 | -$116.80M derived: sum of 4 quarters · filed 2016-02-26 |
| 2015-06-30 | $9.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-03 | -$42.40M 10-Q · filed 2015-08-03 | -$91.10M derived: sum of 3 quarters · filed 2016-02-26 | -$128.40M derived: sum of 4 quarters · filed 2016-02-26 |
| 2015-03-31 | -$51.80M 10-Q · filed 2015-05-06 | -$100.50M derived: sum of 2 quarters · filed 2016-02-26 | -$137.80M derived: sum of 3 quarters · filed 2016-02-26 | -$139.50M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-12-31 | -$48.70M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | -$86.00M derived: sum of 2 quarters · filed 2016-02-26 | -$87.70M derived: sum of 3 quarters · filed 2016-02-26 | -$89.90M 10-K · filed 2016-02-26 |
| 2014-09-30 | -$37.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-03 | -$39.00M derived: sum of 2 quarters · filed 2014-11-03 | -$41.20M 10-Q · filed 2014-11-03 | -$5.90M derived: sum of 4 quarters · filed 2015-02-25 |
| 2014-06-30 | -$1.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01 | -$3.90M 10-Q · filed 2014-08-01 | $31.40M derived: sum of 3 quarters · filed 2015-02-25 | |
| 2014-03-31 | -$2.20M 10-Q · filed 2014-05-08 | $33.10M derived: sum of 2 quarters · filed 2015-02-25 | ||
| 2013-12-31 | $35.30M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $34.50M 10-K · filed 2015-02-25 | ||
| 2013-09-30 | -$800.00K 10-Q · filed 2013-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |